Literature DB >> 32187520

Dysregulated Expression of the Nuclear Exosome Targeting Complex Component Rbm7 in Nonhematopoietic Cells Licenses the Development of Fibrosis.

Kiyoharu Fukushima1, Takashi Satoh2, Fuminori Sugihara3, Yuki Sato4, Toru Okamoto5, Yuichi Mitsui1, Sachiyo Yoshio6, Songling Li7, Satoshi Nojima8, Daisuke Motooka9, Shota Nakamura9, Hiroshi Kida10, Daron M Standley7, Eiichi Morii8, Tatsuya Kanto6, Motoko Yanagita11, Yoshiharu Matsuura5, Takashi Nagasawa12, Atsushi Kumanogoh10, Shizuo Akira13.   

Abstract

Fibrosis is an incurable disorder of unknown etiology. Segregated-nucleus-containing atypical monocytes (SatMs) are critical for the development of fibrosis. Here we examined the mechanisms that recruit SatMs to pre-fibrotic areas. A screen based on cytokine expression in the fibrotic lung revealed that the chemokine Cxcl12, which is produced by apoptotic nonhematopoietic cells, was essential for SatM recruitment. Analyses of lung tissues at fibrosis onset showed increased expression of Rbm7, a component of the nuclear exosome targeting complex. Rbm7 deletion suppressed bleomycin-induced fibrosis and at a cellular level, suppressed apoptosis of nonhematopoietic cells. Mechanistically, Rbm7 bound to noncoding (nc)RNAs that form subnuclear bodies, including Neat1 speckles. Dysregulated expression of Rbm7 resulted in the nuclear degradation of Neat1 speckles, the dispersion of the DNA repair protein BRCA1, and the triggering of apoptosis. Thus, Rbm7 in epithelial cells plays a critical role in the development of fibrosis by regulating ncRNA decay and thereby the production of chemokines that recruit SatMs.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  RNA decay; fibrosis; innate immunity; macrophage; ncRNA

Year:  2020        PMID: 32187520     DOI: 10.1016/j.immuni.2020.02.007

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  12 in total

Review 1.  Emerging Role of Exosomal-Derived Long Noncoding RNAs in Human PDAC.

Authors:  Di Long; Xiao Dong Tian; Yin-Mo Yang
Journal:  Visc Med       Date:  2021-12-20

2.  ETS1 governs pathological tissue-remodeling programs in disease-associated fibroblasts.

Authors:  Minglu Yan; Noriko Komatsu; Ryunosuke Muro; Nam Cong-Nhat Huynh; Yoshihiko Tomofuji; Yukinori Okada; Hiroshi I Suzuki; Hiroyuki Takaba; Riko Kitazawa; Sohei Kitazawa; Warunee Pluemsakunthai; Yuichi Mitsui; Takashi Satoh; Tadashi Okamura; Takeshi Nitta; Sin-Hyeog Im; Chan Johng Kim; George Kollias; Sakae Tanaka; Kazuo Okamoto; Masayuki Tsukasaki; Hiroshi Takayanagi
Journal:  Nat Immunol       Date:  2022-08-23       Impact factor: 31.250

Review 3.  Biology of lung macrophages in health and disease.

Authors:  Helena Aegerter; Bart N Lambrecht; Claudia V Jakubzick
Journal:  Immunity       Date:  2022-09-13       Impact factor: 43.474

4.  Specific targeting of lung ILC2s via NRP1 in pulmonary fibrosis.

Authors:  Takuro Nii; Kiyoharu Fukushima; Hiroshi Kida
Journal:  Cell Mol Immunol       Date:  2022-04-22       Impact factor: 22.096

Review 5.  The Role of Exosomes in Pancreatic Cancer From Bench to Clinical Application: An Updated Review.

Authors:  Kai Chen; Qi Wang; Marko Kornmann; Xiaodong Tian; Yinmo Yang
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

Review 6.  Therapeutic Potential of Exosomes in Pulmonary Fibrosis.

Authors:  Linshen Xie; Ye Zeng
Journal:  Front Pharmacol       Date:  2020-12-04       Impact factor: 5.810

Review 7.  Advances and Challenges of Antibody Therapeutics for Severe Bronchial Asthma.

Authors:  Yuko Abe; Yasuhiko Suga; Kiyoharu Fukushima; Hayase Ohata; Takayuki Niitsu; Hiroshi Nabeshima; Yasuharu Nagahama; Hiroshi Kida; Atsushi Kumanogoh
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

8.  The phosphodiesterase 4 inhibitor AA6216 suppresses activity of fibrosis-specific macrophages.

Authors:  Takashi Matsuhira; Osamu Nishiyama; Yuji Tabata; Shinji Kurashimo; Hiroyuki Sano; Takashi Iwanaga; Yuji Tohda
Journal:  Biochem Biophys Rep       Date:  2021-08-28

9.  Loss of FCHSD1 leads to amelioration of chronic obstructive pulmonary disease.

Authors:  Takahiro Kawasaki; Fuminori Sugihara; Kiyoharu Fukushima; Takanori Matsuki; Hiroshi Nabeshima; Tomohisa Machida; Yuichi Mitsui; Saki Fujimura; Rio Sagawa; Lee Gaheun; Kanako Kuniyoshi; Hiroki Tanaka; Masashi Narazaki; Atsushi Kumanogoh; Shizuo Akira; Takashi Satoh
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-29       Impact factor: 11.205

Review 10.  Nuclear RNA Exosome and Pervasive Transcription: Dual Sculptors of Genome Function.

Authors:  Koichi Ogami; Hiroshi I Suzuki
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.